Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100S8NI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income¥201m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income¥200m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥200m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥135m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥4.0bnat 2023-09-30StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.4bnat 2023-09-30StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥854mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥854mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow¥230m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥436m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥492m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥18.822023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.722023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.332022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥12.252022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥17.922023-04-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥23.742022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
Equity ratio39.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,156,600at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥6m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥230m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-09-30¥298m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-09-30¥206m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-09-30−¥67m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥436m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥431m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥192m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥339m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥144m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥443m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥447m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　本　芳　樹
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)下　平　雅　和
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember3168844000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember3899214000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember6657448000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember263470000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember199805000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember557751000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember178862000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember134647000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember382876000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember185220000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember187121000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember185912000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember3568400
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember7156600
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember3572000
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1277738000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1576836000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1483134000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember2751099000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember3971619000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2914911000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember25.33
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember18.82
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember53.92
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember23.74
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember17.92
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember50.82
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.464
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.397
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.509
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember96723000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember230382000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration_NonConsolidatedMember342252000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember-193145000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember-436354000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-383393000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember56823000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember491983000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-110728000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass